The University of Kansas Cancer Center

https://www.kucancercenter.org/

 

The University of Kansas Cancer Center
J

HaploSCT: Choosing an Optimal Donor and Novel Strategies to Mitigate Post-HaploSCT Relapse and Improve Immune Reconstitution

By The University of Kansas Cancer Center FEATURING Joseph McGuirk
By The University of Kansas Cancer Center FEATURING Joseph McGuirk
19 views
June 2, 2022
0 Comments
Login to view comments. Click here to Login

Featured Video

15:14
Icahn School of Medicine at Mount Sinai

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay

Featured Video

13:04
Winship Cancer Institute - Emory University

Treatment-Related Quality of Life in MF

Feat. A. Hunter
Advances in Hematologic Malignancies and Cellular Therapeutics Symposium
40:05
The University of Kansas Cancer Center

Mitigating Toxicities Associated With CAR T-Cell Therapies

Feat. S. Kenderian
30:52
The University of Kansas Cancer Center

Treatment of Aggressive B-Cell Lymphoma: SCT vs. CAR-T

Feat. M. Hamadani
30:18
The University of Kansas Cancer Center

Survivorship and Late Effects After Stem Cell Transplantation and CA…

Feat. N. Ahmed
41:31
The University of Kansas Cancer Center

HaploSCT: Choosing an Optimal Donor and Novel Strategies to Mitigate…

Feat. J. McGuirk
43:41
The University of Kansas Cancer Center

Prevention and Treatment of Disease Relapse After Allogeneic HCT

Feat. R. Soiffer
30:51
The University of Kansas Cancer Center

Preventing Post-Transplant Relapse With Targeted Therapies

Feat. M. Levis